Advertisement
Advertisement
IART
Integra LifeSciences Holdings
17.12
USDSponsored
+0.63
+3.82%
Jul 30, 15:59 UTC -4
Closed
Pre-Market
17.13
0.00
+0.03%
IART Earnings Reports
Positive Surprise Ratio
IART beat 26 of 43 last estimates.
60%
Next Report
Date of Next Report
Oct 28, 2026
Estimate for Q3 26 (Revenue/ EPS)
$426.26M
/$0.57
Implied change from Q2 26 (Revenue/ EPS)
+1.79%
/+1.79%
Implied change from Q3 25 (Revenue/ EPS)
+6.02%
/+5.56%
Integra LifeSciences Holdings earnings per share and revenue
On Jul 29, 2026, IART reported earnings of 0.56 USD per share (EPS) for Q2 26, beating the estimate of 0.49 USD, resulting in a 13.57% surprise. Revenue reached 418.76 million, compared to an expected 427.02 million, with a -1.93% difference. The market reacted with a -16.55% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 10 analysts forecast an EPS of 0.57 USD, with revenue projected to reach 426.26 million USD, implying an increase of 1.79% EPS, and increase of 1.79% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Axogen, Inc. Common Stock
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.12
Actual
$0.12
Surprise
-5.88%
Opko Health Inc.
Report Date
Jul 27, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.01
Surprise
+87.62%
Beta Bionics, Inc. Common Stock
Report Date
Jul 29, 2026 For Q2 26
Estimate
-$0.60
Actual
-$0.53
Surprise
+12.77%
Thermo Fisher Scientific, Inc.
Report Date
Jul 23, 2026 For Q2 26
Estimate
$5.76
Actual
$6.03
Surprise
+4.54%
Edwards Lifesciences Corp
Report Date
Jul 23, 2026 For Q2 26
Estimate
$0.76
Actual
$0.78
Surprise
+2.13%
IQVIA Holdings Inc.
Report Date
Jul 28, 2026 For Q2 26
Estimate
$3.06
Actual
$3.15
Surprise
+2.92%
Mettler-Toledo International
Report Date
Jul 30, 2026 For Q2 26
Estimate
$10.89
Actual
$11.46
Surprise
+5.18%
DexCom, Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$0.62
Actual
$0.70
Surprise
+12.54%
Glaukos Corporation
Report Date
Jul 29, 2026 For Q2 26
Estimate
-$0.22
Actual
-$0.14
Surprise
+38.52%
Veracyte, Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$0.24
Actual
$0.54
Surprise
+123.23%
FAQ
What were Integra LifeSciences Holdings's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Integra LifeSciences Holdings reported EPS of $0.56, beating estimates by 13.57%, and revenue of $418.76M, -1.93% below expectations.
How did the market react to Integra LifeSciences Holdings's Q2 2026 earnings?
The stock price moved down -16.55%, changed from $19.76 before the earnings release to $16.49 the day after.
When is Integra LifeSciences Holdings expected to report next?
The next earning report is scheduled for Oct 28, 2026.
What are the forecasts for Integra LifeSciences Holdings's next earnings report?
Based on 10
analysts, Integra LifeSciences Holdings is expected to report EPS of $0.57 and revenue of $426.26M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement